Selective Targeting of TNF Receptors as a Novel Therapeutic ApproachRoman Fischer, Klaus Pfizenmaier|Frontiers in Cell and Developmental Biology|2020Cited by 240
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell DeathRoman Fischer, Klaus Pfizenmaier|PLoS ONE|2011Cited by 126
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95LDaniela Berg, Harald Wajant, Sabine Münkel et al.|Cell Death and Differentiation|2007Cited by 117
Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivityMartin Siegemund, Klaus Pfizenmaier|Cell Death and Disease|2012Cited by 67
Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion ProteinIrene Marini, Klaus Pfizenmaier|Frontiers in Immunology|2017Cited by 16